NO152698C - Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzosyrederivater. - Google Patents
Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzosyrederivater.Info
- Publication number
- NO152698C NO152698C NO801297A NO801297A NO152698C NO 152698 C NO152698 C NO 152698C NO 801297 A NO801297 A NO 801297A NO 801297 A NO801297 A NO 801297A NO 152698 C NO152698 C NO 152698C
- Authority
- NO
- Norway
- Prior art keywords
- hydroxy
- piperazinylethyl
- preparation
- benzoic acid
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/036,244 US4255575A (en) | 1979-05-04 | 1979-05-04 | 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO801297L NO801297L (no) | 1980-11-05 |
| NO152698B NO152698B (no) | 1985-07-29 |
| NO152698C true NO152698C (no) | 1985-11-20 |
Family
ID=21887503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO801297A NO152698C (no) | 1979-05-04 | 1980-05-02 | Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzosyrederivater. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4255575A (fr) |
| JP (1) | JPS55147262A (fr) |
| AT (1) | AT376426B (fr) |
| AU (1) | AU531738B2 (fr) |
| BE (1) | BE883086A (fr) |
| CA (1) | CA1138457A (fr) |
| CH (1) | CH645368A5 (fr) |
| DE (1) | DE3014813A1 (fr) |
| DK (1) | DK159435C (fr) |
| ES (1) | ES8104995A1 (fr) |
| FR (1) | FR2455590A1 (fr) |
| GB (1) | GB2053897B (fr) |
| IE (1) | IE49549B1 (fr) |
| IL (1) | IL59596A (fr) |
| IT (1) | IT1143190B (fr) |
| NL (1) | NL8002071A (fr) |
| NO (1) | NO152698C (fr) |
| NZ (1) | NZ193107A (fr) |
| PH (1) | PH17089A (fr) |
| SE (1) | SE447109B (fr) |
| ZA (1) | ZA801453B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3400168A1 (de) * | 1984-01-04 | 1985-07-11 | Bayer Ag, 5090 Leverkusen | 5-halogenalkyl-1,3,4-thiadiazol-2-yloxyacetamide |
| US4616017A (en) * | 1984-06-04 | 1986-10-07 | Merck & Co., Inc. | Aminohydroxypropoxy substituted aryl compounds |
| DE3505425A1 (de) * | 1985-02-16 | 1986-08-21 | Bayer Ag, 5090 Leverkusen | 5-chlor-1,3,4-thiadiazol-2-yloxy-acetamide |
| GB8603120D0 (en) * | 1986-02-07 | 1986-03-12 | Pfizer Ltd | Anti-dysrhythmia agents |
| GB8609630D0 (en) * | 1986-04-19 | 1986-05-21 | Pfizer Ltd | Anti-arrhythmia agents |
| US4956302A (en) | 1987-09-11 | 1990-09-11 | Abbott Laboratories | Lateral flow chromatographic binding assay device |
| DE3812755A1 (de) * | 1988-04-16 | 1989-10-26 | Merck Patent Gmbh | Salicylsaeurederivate |
| KR100484386B1 (ko) * | 2000-10-04 | 2005-04-22 | 경동제약 주식회사 | 알킬2-[2,3,5-트리플루오로-4-(4-메틸-1-피페라지닐)]벤조일-3(ｓ)-(1-히드록시프로피-2-닐아미노)아크릴레이트의 제조방법 |
| US20080131954A1 (en) * | 2006-11-30 | 2008-06-05 | Canon U.S. Life Sciences, Inc. | Method of Separating Target DNA from Mixed DNA |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1317479A (en) * | 1970-11-10 | 1973-05-16 | Pfizer Ltd | 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives |
| US4038279A (en) * | 1972-12-23 | 1977-07-26 | Boehringer Ingelheim Gmbh | N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof |
| CA1113937A (fr) * | 1977-04-05 | 1981-12-08 | Frederic P. Hauck | Piperidinylpropanols substitues |
-
1979
- 1979-05-04 US US06/036,244 patent/US4255575A/en not_active Expired - Lifetime
-
1980
- 1980-03-10 IE IE481/80A patent/IE49549B1/en not_active IP Right Cessation
- 1980-03-12 ZA ZA00801453A patent/ZA801453B/xx unknown
- 1980-03-12 NZ NZ193107A patent/NZ193107A/xx unknown
- 1980-03-12 IL IL59596A patent/IL59596A/xx unknown
- 1980-03-21 PH PH23798A patent/PH17089A/en unknown
- 1980-03-26 IT IT48267/80A patent/IT1143190B/it active
- 1980-04-02 AU AU57076/80A patent/AU531738B2/en not_active Expired
- 1980-04-09 NL NL8002071A patent/NL8002071A/nl not_active Application Discontinuation
- 1980-04-17 CA CA000350105A patent/CA1138457A/fr not_active Expired
- 1980-04-17 ES ES490667A patent/ES8104995A1/es not_active Expired
- 1980-04-17 DE DE19803014813 patent/DE3014813A1/de not_active Withdrawn
- 1980-04-18 JP JP5054880A patent/JPS55147262A/ja active Granted
- 1980-04-22 CH CH309180A patent/CH645368A5/de not_active IP Right Cessation
- 1980-04-25 GB GB8013781A patent/GB2053897B/en not_active Expired
- 1980-04-29 SE SE8003244A patent/SE447109B/sv not_active IP Right Cessation
- 1980-04-30 AT AT0232580A patent/AT376426B/de not_active IP Right Cessation
- 1980-04-30 FR FR8009850A patent/FR2455590A1/fr active Granted
- 1980-05-01 DK DK193680A patent/DK159435C/da not_active IP Right Cessation
- 1980-05-02 NO NO801297A patent/NO152698C/no unknown
- 1980-05-02 BE BE0/200446A patent/BE883086A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU5707680A (en) | 1980-11-06 |
| IL59596A (en) | 1984-01-31 |
| AU531738B2 (en) | 1983-09-01 |
| FR2455590B1 (fr) | 1983-10-14 |
| AT376426B (de) | 1984-11-26 |
| BE883086A (fr) | 1980-09-01 |
| DE3014813A1 (de) | 1980-11-13 |
| GB2053897B (en) | 1982-10-20 |
| FR2455590A1 (fr) | 1980-11-28 |
| US4255575A (en) | 1981-03-10 |
| IE49549B1 (en) | 1985-10-30 |
| NO801297L (no) | 1980-11-05 |
| DK159435C (da) | 1991-03-25 |
| IL59596A0 (en) | 1980-06-30 |
| DK193680A (da) | 1980-11-05 |
| ES490667A0 (es) | 1981-05-16 |
| SE8003244L (sv) | 1980-11-05 |
| JPS55147262A (en) | 1980-11-17 |
| NZ193107A (en) | 1982-12-21 |
| NO152698B (no) | 1985-07-29 |
| DK159435B (da) | 1990-10-15 |
| JPS6321666B2 (fr) | 1988-05-09 |
| ES8104995A1 (es) | 1981-05-16 |
| NL8002071A (nl) | 1980-11-06 |
| SE447109B (sv) | 1986-10-27 |
| IT8048267A0 (it) | 1980-03-26 |
| CA1138457A (fr) | 1982-12-28 |
| ATA232580A (de) | 1984-04-15 |
| IE800481L (en) | 1980-11-04 |
| CH645368A5 (de) | 1984-09-28 |
| GB2053897A (en) | 1981-02-11 |
| IT1143190B (it) | 1986-10-22 |
| ZA801453B (en) | 1980-12-31 |
| PH17089A (en) | 1984-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO154521C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive piperidinderivater. | |
| NO154346C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater. | |
| NO159019C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater. | |
| NO155055C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater. | |
| NO153136C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater. | |
| NO151085C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater | |
| NO158679C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-penem-3-karboksylsyreforbindelser. | |
| NO803338L (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme acetohydroksamsyrer | |
| NO157979C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive benzotiazindioksyd-salter. | |
| NO149733C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive acylderivater av carnitin | |
| NO150884C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater | |
| NO152654C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre | |
| NO148642C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater | |
| NO148926C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater | |
| NO154268C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere. | |
| NO800857L (no) | Fremgangsmaate for fremstilling av nye antisekretorisk aktive forbindelser. | |
| NO152698C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzosyrederivater. | |
| NO165679C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme androstan-17beta-karboksyl-syreestere. | |
| NO154396C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive halovincamonderivater. | |
| NO800920L (no) | Fremgangsmaate til fremstilling av nye 1,8-dihydroksy-10-acyl-9-antroner for behandling av psoriasis | |
| NO164243C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater | |
| MX3745E (es) | Procedimiento para la preparacion de acido 6,11-dihidro-11-oxodibenz-(b,e)oxepin-2-alcanoico | |
| NO154794C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrrolidinylsulfamoylbenzosyrederivater. | |
| SE7610968L (sv) | Forfarande for framstellning av biologiskt aktiva di-karboxylsyraderivat | |
| MX6164E (es) | Procedimiento microbiologico mejorado para la preparacion del acido 2,5-dicetogluconico |